维普中文期刊产品整合服务
35篇 您的检索式:作者名="PIZOV G"
    题名 作者 年代 出处 被引量
1Oct-3/4 is a dose-dependent oncogenic fate determinant 显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
2Oct3/4 is a dose-dependent oncogenic fate determinant 显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
30ct-3/4 is a dose-dependent oncogenie fate determinant 显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
40ct-3/4 is a dosedependent oncogenic fate determinant显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
5IL-6 / IL-6R axis plays a critical role in acute kidney injury显示文摘Nechemia-Arbely Y Barkan D Pizov G 2008J Am Soc Nephrol2008,19,6:1
6Oct-3/4 is a dose -dependent oncogenic fate determinant显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
7Oct-3/4 is a dose-dependent oncogenic fate determinant显示文摘GIDEKEL S PIZOV G BERGMAN Y 2003Cancer Cell2003,4,5:1
8Oct-3/4 is a dose- dependent oncogenic fate determinant显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
9IL-6/ IL-6R axis plays a critical role in acute kidney injury 显示文摘Nechemia-Arbely Y Barkan D Pizov G 2008J Am Soc Nephrol2008,19,6:1
10Seminal vesicle cystadenoma: a rare clinical perspective 显示文摘Lorber G Pizov G Gofrit ON 2011Eur Urol2011,60,2:1
11Oct-3/4 is a dose-dependent oncogenic fate determinant 显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
12Correlation of pathologic findings with progression after radical retropubic prostatectomy 显示文摘Epstein JI Pizov G Walsh PC 1993Cancer1993,71,:1
13Hyperacute renal failure as the initial presentation of systemic lupus erythcmatosus显示文摘Arbel O Pizov G Ben-Yehuda A 2005Lupus2005,14,4:1
14Oct-3/4 is a dose-dependent onco- genie fate determinant 显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
15Effect of KRN7000 on induced graft-vs-host disease 显示文摘Morecki S Panigrahi S Pizov G 2004Exp He matol2004,32,:1
16Oct-3/4 is a dose-dependent oncogenic fate determinant 显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Ce112003,4,:1
17Oct3 / 4 is adose-dependent oneogenic fate determinant显示文摘Gidekel S Pizov G Bergaman Y 2003Cancer Cell2003,4,5:1
18Oct3/4 is a dose-dependent oneogenic fate determinant显示文摘Gidekel S Pizov G Bergman Y 2003Cancer Cell2003,4,5:1
19Oct-3/4 is a dose-dependent oncogenic fate determinant显示文摘Gidekel S Pizov G Bergamn Y 2003Cancer Cell2003,4,5:1
20Does stage T3a re- nal cell carcinoma embrace a homogeneous group of patients? 显示文摘GOFRIT ON SHAPIRO A PIZOV G 2007J Urol2007,177,5:1
返回顶部 每页显示:
共2页 首页 上一页 第1页 下一页 末页 /2 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费